![]() Prior to this, he has worked at Logitech as Chief Accounting Officer, Vice President and Corporate Controller. “We believe he will make an excellent addition to Bio-Rad.”Ījit Ramalingam, Senior Vice President, Chief Accounting OfficerĪjit Ramalingam serves as the Senior Vice President and Chief Accounting Officer of the company. “Ilan brings a breadth of experience in finance, operations, IT, as well as mergers and acquisitions, all in a global setting,” said Norman Schwartz, Bio-Rad President and CEO. Daskal holds a Masters in Finance degree from City University of New York and a BB in Accounting from Tel-Aviv College of Business in Israel. He has over 25 years of experience in senior financial roles and has held several CFO positions at both public and private companies that include International Rectifier Corporation and Infineon. Daskal comes to Bio-Rad from Lumileds, where he served as Chief Financial Officer. Ilan Daskal, Executive Vice President, Chief Financial Officer Last graduated from Cranfield University with a PhD in agrochemicals and an MS in bio-aeronautics and from University of Leicester with an undergraduate degree in biological sciences. Earlier in his career he worked with Monsanto Company as a director of global category management. ![]() and before that a Chief Operating Officer at Intrexon Corporation. He began his career in 1996.īefore joining Bio-Rad Laboratories, Last was a Chief Commercial Officer at Berkeley Lights, Inc. Schwartz has been President and Chief Executive Officer since 2003 and Chairman of the Board since 2012.Īndrew Last, Executive Vice President, Chief Operating OfficerĪndrew Last is the Chief Operating Officer of Bio-Rad Laboratories. Schwartz is Chairman of the Board, President, Chief Executive Officer of Bio Rad Laboratories Inc. Norman Schwartz, Chairman of the Board, President and Chief Executive Officer – Microbiology and Biological Pathway Kits – pGLO Bacterial Transformation and GFP Kits – DNA Extraction and Electrophoresis Kits – Protein Expression and Purification Series – Process-Scale Prepacked Chromatography Columns - GMP Ready – Hydrophobic Interaction Chromatography Resins – Circulating Tumor Cell (CTC) Enrichment and Enumeration Bio-Rad’s products and solutions are based on technologies to separate, purify, identify, analyze, and amplify biological materials such as antibodies, proteins, nucleic acids, cells, and bacteria. Bio-Rad customers include university and research institutions, hospitals, public health and commercial laboratories, biotechnology, pharmaceutical, as well as applied laboratories that include food safety and environmental quality.īio-Rad is among the top five life science companies in the world, providing instruments, software, consumables, reagents, and content for the areas of cell biology, gene expression, protein purification, protein quantitation, drug discovery and manufacture, food safety, and science education. With a focus on quality and customer service for 70 years, their products advance the discovery process and improve healthcare. We also continue to work closely with their group on brand positioning, sales campaigns and themes, and corporate imagery.Bio-Rad is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. All writing, design, art direction, illustration and photography, and production is handled by 405 Group. ![]() The Bio-Rad Corporate Communications group has worked with 405 Group since 2005 on various projects-from annual reports to marketing collateral. But today, Bio-Rad supplies life science research, healthcare, chemistry, and other markets with products and systems to separate complex chemical and biological materials and to identify, analyze, and purify their components. The company was initially engaged in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. Today, from humble beginnings, the company has a market capitalization of over $4 billion dollars-and I bet you’ve never heard of them. was founded in 1952 in Berkeley, California by David and Alice Schwartz.
0 Comments
Leave a Reply. |